<DOC>
	<DOCNO>NCT02295683</DOCNO>
	<brief_summary>The purpose study document safety efficacy renal sympathetic denervation treatment subject uncontrolled hypertension use Iberis renal denervation system .</brief_summary>
	<brief_title>Renal Sympathetic Denervation Iberis System Patients With Uncontrolled Hypertension - Iberis-HTN Registry</brief_title>
	<detailed_description>This study prospective , multi-center , single-arm , non-interventional open-label registry collect descriptive data patient receive renal sympathetic denervation treatment accordance routine hospital practice use Iberis system . This registry collect data prospectively patient receive renal sympathetic denervation treatment use Iberis renal denervation system treatment apply accord routine hospital practice . No additional test require specific registry . The registry serve tool collect clinical data order expand knowledge base safety , efficacy functionality Iberis system patient resistant hypertension . A minimum 30 patient enrol Europe</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Age â‰¥18 year minimum age require local regulation . Patient thoroughly inform registry sign Informed Consent Form . Patient true resistant hypertension define : Office systolic BP high 160 150mmHg case type 2 diabetes Ambulatory BP average BP &gt; 130mmHg mean daytime &gt; 135mmHg 70 % measurement . Patients stable hypertension therapy least 8 week procedure , include spironolactone suppose respondent indicate specialized center/excellence unit hypertension . Previous renal artery intervention ( balloon angioplasty stenting ) . Evidence renal artery atherosclerosis ( defined renal artery stenosis &gt; 50 % ) . Main renal artery less 4mm diameter less 20mm length . Presence multiple main renal artery either kidney . Estimated glomerular filtration rate &lt; 45ml/min per 1,73m2 Recent myocardial infarction , unstable angina pectoris cerebrovascular accident within past 36 month . False resistant hypertension ( pseudo resistance ) use 24h ambulatory BP monitoring ( ABPM ) . Secondary arterial hypertension . Pregnancy . There another pathological process wellknown life expectancy le 5 year . Patient unable correct FU . Unable take correct ambulatory BP . Primary hyperaldosteronism . Known lack adherence medical treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>